Brexit Forces Biggest Insulin Supplier to Turn to the Skies
Today’s extraordinarily profitable drugs have investors demanding massive followups.
Bayer Gains as Judge Limits Evidence in Roundup Cancer Cases
Biggest Pharma Deal Ever Propels Bristol-Myers to No. 1 in Cancer Market
Big Pharma Cures Its Consumer Headache by Splitting Off Painkillers
Singer's Elliott Builds Bayer Stake in Breakup Push
Bayer's Health Unit Pinches Pennies With Monsanto Draining Cash
Bayer AG plans to cut 12,000 jobs and exit its animal health business in an effort to mollify Wall Street.
Gene-Edited Twins in China Still Face Risk of HIV Infection
Cancer Breakthroughs Are Set to Elude World's Poor, Study Says
Bayer Faces Roundup Woes at Home Now
Medtronic, which sells about $2 billion worth of diabetes devices a year, has come to regard the DIY community as allies.
Lundbeck Plunges 30% After a Key Experimental Drug Failed
Breaking Into Breast Cancer, Immune Therapy Shows Wider Promise
Roche Immune Drug Helps Patients With Aggressive Breast Cancers
Astra's Lynparza Boosts Survival in Ovarian Cancer Patients
Sneaking Into Patients’ Pockets, One Medical App at a Time
Roche Wins U.S. Nod to Sell Hemlibra to Most Hemophilia Patients
Roche Left Seeking a Niche as Merck Dominates Lung-Cancer Market
Italy's Salvini, Luxembourg's Asselborn Locked in War of Words
Roche CEO Refuses to Cede Cancer's Hottest New Field to Merck